0001533615 false 0001533615 2023-05-03 2023-05-03 0001533615 us-gaap:CommonStockMember 2023-05-03 2023-05-03 0001533615 us-gaap:SeriesAPreferredStockMember 2023-05-03 2023-05-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares





Washington, D.C. 20549









Date of Report (Date of earliest event reported): May 3, 2023 (May 3, 2023)


Global Medical REIT Inc.

(Exact name of registrant as specified in its charter)


Maryland 001-37815 46-4757266
(State or Other Jurisdiction
of Incorporation)
File Number)
(I.R.S. Employer
Identification No.)


7373 Wisconsin Avenue, Suite 800

Bethesda, MD


(Address of Principal Executive Offices)

(Zip Code)


(202) 524-6851

(Registrant’s Telephone Number, Including Area Code)


Not Applicable

(Former name or former address, if changed since last report)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class:   Trading Symbols:   Name of each exchange on which registered:
Common Stock, par value $0.001 per share   GMRE   NYSE
Series A Preferred Stock, par value $0.001 per share   GMRE PrA   NYSE


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).


Emerging growth company ¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨






Item 2.02 Results of Operations and Financial Condition.


On May 3, 2023, Global Medical REIT Inc. (the “Company”) announced its financial position as of March 31, 2023 and operating results for the three months ended March 31, 2023 and other related information (the “Earnings Release”). The Company also posted its First Quarter 2023 Earnings Supplemental (the “Supplemental”) to the Company’s website at www.globalmedicalreit.com. The Earnings Release and Supplemental are furnished as Exhibit 99.1 and Exhibit 99.2, respectively, and are incorporated herein by reference.


The information included in this Item 2.02 of this Current Report on Form 8-K, including the Earnings Release and Supplemental, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. 


Item 9.01 Financial Statements and Exhibits.


(d)  Exhibits


Exhibit No.   Description
99.1*   First Quarter 2023 Earnings Release.
99.2*   First Quarter 2023 Earnings Supplemental.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)


*Furnished herewith







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  Global Medical REIT Inc.
  By: /s/ Jamie A. Barber
    Jamie A. Barber
    Secretary and General Counsel


Date: May 3, 2023